Brief: NexPoint Asset Management Sends Open Letter To Board Of Paratek Pharmaceuticals
27/06/2023 14:43
June 27 (Reuters) - Paratek Pharmaceuticals Inc
PRTK.O :
* NEXPOINT ASSET MANAGEMENT SENDS OPEN LETTER TO THE BOARD
OF
PARATEK PHARMACEUTICALS REGARDING UPCOMING ANNUAL MEETING AND
PROPOSED ACQUISITION BY GURNET POINT CAPITAL
* NEXPOINT ASSET MANAGEMENT: INTENDS TO WITHHOLD ITS VOTES
AGAINST
ALL THREE PARATEK BOARD MEMBERS UP FOR ELECTION AT ANNUAL
MEETING
* NEXPOINT ASSET MANAGEMENT: TO "CAREFULLY SCRUTINIZE"
PROCESS
UNDERTAKEN BY PARATEK BOARD IN APPROVING PROPOSED SALE, MAY VOTE
AGAINST PROPOSED DEAL
Source text for Eikon: ID:nPn1hQkjga
Further company coverage: PRTK.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Paratek Pharmaceuticals
See all newsNovo Holdings closes $462 mln acquisition of Paratek Pharmaceuticals
Brief: Glass Lewis Recommends Paratek Pharmaceuticals Stockholders Vote For Acquisition By Gurnet Point Capital And Novo Holdings
Brief: Paratek Pharmaceuticals Responds to Demand Letters From 11 Stockholders Alleging 'Misleading', Incomplete Statements In Proxy Statement Filed On June 30
Brief: Independent Proxy Advisory Firm ISS Recommends Paratek Pharmaceuticals Stockholders Vote For Acquisition By Gurnet Point Capital And Novo Holdings
Brief: Paratek Pharmaceuticals Announces Second Quarter 2023 Revenue Of $40.0 Million